The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: A five- year cohort study in Southwest China

Elizabeth J. Carlton, Michelle Hsiang, Yi Zhang, Sarah Johnson, Alan Hubbard, Robert C. Spear

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Background: Ultrasonography allows for non-invasive examination of the liver and spleen and can further our understanding of schistosomiasis morbidity. Methodology/Principal Findings: We followed 578 people in Southwest China for up to five years. Participants were tested for Schistosoma japonicum infection in stool and seven standard measures of the liver and spleen were obtained using ultrasound to evaluate the relationship between schistosomiasis infection and ultrasound-detectable pathology, and the impact of targeted treatment on morbidity. Parenchymal fibrosis, a network pattern of the liver unique to S. japonicum, was associated with infection at the time of ultrasound (OR 1.40, 95% CI: 1.03-1.90) and infection intensity (test for trend, p = 0.002), adjusting for age, sex and year, and more strongly associated with prior infection status and intensity (adjusted OR 1.84, 95% CI: 1.30-2.60; test for trend: p<0.001 respectively), despite prompt treatment of infections. While declines in parenchymal fibrosis over time were statistically significant, only 28% of individuals with severe parenchymal fibrosis (grades 2 or 3) at enrollment reversed to normal or grade 1 within five years. Other liver abnormalities were less consistently associated with S. japonicum infection. Conclusions/Significance: Parenchymal fibrosis is an appropriate measure of S. japonicum morbidity and can document reductions in disease following control efforts. Other ultrasound measures may have limited epidemiological value in regions with similar infection levels. Because severe fibrosis may not reverse quickly following treatment, efforts to reduce exposure to S. japonicum should be considered in combination with treatment to prevent schistosomiasis morbidity. Copyright:

Original languageEnglish (US)
Title of host publicationPLoS Neglected Tropical Diseases
Volume4
Edition5
DOIs
StatePublished - May 18 2010

Fingerprint

Schistosoma japonicum
China
Cohort Studies
Morbidity
Infection
Fibrosis
Schistosomiasis
Liver
Spleen
Ultrasonography
Pathology

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Carlton, E. J., Hsiang, M., Zhang, Y., Johnson, S., Hubbard, A., & Spear, R. C. (2010). The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: A five- year cohort study in Southwest China. In PLoS Neglected Tropical Diseases (5 ed., Vol. 4). [e685] https://doi.org/10.1371/journal.pntd.0000685

The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity : A five- year cohort study in Southwest China. / Carlton, Elizabeth J.; Hsiang, Michelle; Zhang, Yi; Johnson, Sarah; Hubbard, Alan; Spear, Robert C.

PLoS Neglected Tropical Diseases. Vol. 4 5. ed. 2010. e685.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carlton, Elizabeth J. ; Hsiang, Michelle ; Zhang, Yi ; Johnson, Sarah ; Hubbard, Alan ; Spear, Robert C. / The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity : A five- year cohort study in Southwest China. PLoS Neglected Tropical Diseases. Vol. 4 5. ed. 2010.
@inbook{8dfe6a34b8b44a1bafcba7715b8fbc64,
title = "The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: A five- year cohort study in Southwest China",
abstract = "Background: Ultrasonography allows for non-invasive examination of the liver and spleen and can further our understanding of schistosomiasis morbidity. Methodology/Principal Findings: We followed 578 people in Southwest China for up to five years. Participants were tested for Schistosoma japonicum infection in stool and seven standard measures of the liver and spleen were obtained using ultrasound to evaluate the relationship between schistosomiasis infection and ultrasound-detectable pathology, and the impact of targeted treatment on morbidity. Parenchymal fibrosis, a network pattern of the liver unique to S. japonicum, was associated with infection at the time of ultrasound (OR 1.40, 95{\%} CI: 1.03-1.90) and infection intensity (test for trend, p = 0.002), adjusting for age, sex and year, and more strongly associated with prior infection status and intensity (adjusted OR 1.84, 95{\%} CI: 1.30-2.60; test for trend: p<0.001 respectively), despite prompt treatment of infections. While declines in parenchymal fibrosis over time were statistically significant, only 28{\%} of individuals with severe parenchymal fibrosis (grades 2 or 3) at enrollment reversed to normal or grade 1 within five years. Other liver abnormalities were less consistently associated with S. japonicum infection. Conclusions/Significance: Parenchymal fibrosis is an appropriate measure of S. japonicum morbidity and can document reductions in disease following control efforts. Other ultrasound measures may have limited epidemiological value in regions with similar infection levels. Because severe fibrosis may not reverse quickly following treatment, efforts to reduce exposure to S. japonicum should be considered in combination with treatment to prevent schistosomiasis morbidity. Copyright:",
author = "Carlton, {Elizabeth J.} and Michelle Hsiang and Yi Zhang and Sarah Johnson and Alan Hubbard and Spear, {Robert C.}",
year = "2010",
month = "5",
day = "18",
doi = "10.1371/journal.pntd.0000685",
language = "English (US)",
volume = "4",
booktitle = "PLoS Neglected Tropical Diseases",
edition = "5",

}

TY - CHAP

T1 - The impact of schistosoma japonicum infection and treatment on ultrasound-detectable morbidity

T2 - A five- year cohort study in Southwest China

AU - Carlton, Elizabeth J.

AU - Hsiang, Michelle

AU - Zhang, Yi

AU - Johnson, Sarah

AU - Hubbard, Alan

AU - Spear, Robert C.

PY - 2010/5/18

Y1 - 2010/5/18

N2 - Background: Ultrasonography allows for non-invasive examination of the liver and spleen and can further our understanding of schistosomiasis morbidity. Methodology/Principal Findings: We followed 578 people in Southwest China for up to five years. Participants were tested for Schistosoma japonicum infection in stool and seven standard measures of the liver and spleen were obtained using ultrasound to evaluate the relationship between schistosomiasis infection and ultrasound-detectable pathology, and the impact of targeted treatment on morbidity. Parenchymal fibrosis, a network pattern of the liver unique to S. japonicum, was associated with infection at the time of ultrasound (OR 1.40, 95% CI: 1.03-1.90) and infection intensity (test for trend, p = 0.002), adjusting for age, sex and year, and more strongly associated with prior infection status and intensity (adjusted OR 1.84, 95% CI: 1.30-2.60; test for trend: p<0.001 respectively), despite prompt treatment of infections. While declines in parenchymal fibrosis over time were statistically significant, only 28% of individuals with severe parenchymal fibrosis (grades 2 or 3) at enrollment reversed to normal or grade 1 within five years. Other liver abnormalities were less consistently associated with S. japonicum infection. Conclusions/Significance: Parenchymal fibrosis is an appropriate measure of S. japonicum morbidity and can document reductions in disease following control efforts. Other ultrasound measures may have limited epidemiological value in regions with similar infection levels. Because severe fibrosis may not reverse quickly following treatment, efforts to reduce exposure to S. japonicum should be considered in combination with treatment to prevent schistosomiasis morbidity. Copyright:

AB - Background: Ultrasonography allows for non-invasive examination of the liver and spleen and can further our understanding of schistosomiasis morbidity. Methodology/Principal Findings: We followed 578 people in Southwest China for up to five years. Participants were tested for Schistosoma japonicum infection in stool and seven standard measures of the liver and spleen were obtained using ultrasound to evaluate the relationship between schistosomiasis infection and ultrasound-detectable pathology, and the impact of targeted treatment on morbidity. Parenchymal fibrosis, a network pattern of the liver unique to S. japonicum, was associated with infection at the time of ultrasound (OR 1.40, 95% CI: 1.03-1.90) and infection intensity (test for trend, p = 0.002), adjusting for age, sex and year, and more strongly associated with prior infection status and intensity (adjusted OR 1.84, 95% CI: 1.30-2.60; test for trend: p<0.001 respectively), despite prompt treatment of infections. While declines in parenchymal fibrosis over time were statistically significant, only 28% of individuals with severe parenchymal fibrosis (grades 2 or 3) at enrollment reversed to normal or grade 1 within five years. Other liver abnormalities were less consistently associated with S. japonicum infection. Conclusions/Significance: Parenchymal fibrosis is an appropriate measure of S. japonicum morbidity and can document reductions in disease following control efforts. Other ultrasound measures may have limited epidemiological value in regions with similar infection levels. Because severe fibrosis may not reverse quickly following treatment, efforts to reduce exposure to S. japonicum should be considered in combination with treatment to prevent schistosomiasis morbidity. Copyright:

UR - http://www.scopus.com/inward/record.url?scp=77955289939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955289939&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0000685

DO - 10.1371/journal.pntd.0000685

M3 - Chapter

C2 - 20502515

AN - SCOPUS:77955289939

VL - 4

BT - PLoS Neglected Tropical Diseases

ER -